USD 3.8M for managing complex chronic conditions

Please login or
register
07.03.2022
Juli app

Based in Boston and St. Gallen, juli is an AI-powered digital health platform empowering patients and their care teams to manage complex chronic conditions. Over 15,000 patients have used the juli app since its launch in 2021. The startup has now secured $3.8 million in a seed-funding round led by Speedinvest and Norrsken VC to grow its US base and accelerate clinical developments.

Chronic and mental health conditions account for 90% of U.S. healthcare expenditures. juli harnesses AI to help patients (and their caregivers) gain control over their conditions. The AI-powered app combines patient-provided data, environmental data, and a patient's social and behavioral context, to identify micro-behavioral changes that can improve their health.  The company supports patients with chronic health conditions like asthma, migraine, depression, bipolar disorder, and chronic pain through a number of evidence-based approaches, and uniquely unites multiple health data sources in one place.

Since launching a year ago, approximately 15,000 patients have used the juli app to track data for chronic, debilitating conditions. The company has already earned high-profile awards, including Best New Company of 2021 by MassTLC, it was selected by the U.S. Department of Health and Human Services as one of 15 digital health startups to join the 2022 PandemicX Accelerator cohort, and is one of only nine companies selected into SoftBank Vision Fund’s Emerge Program for 2021.

The new investment is led by Speedinvest, one of Europe’s most active early-stage venture capital firms, and Norrsken VC. SoftBank’s Vision Fund Emerge Program and Dieter Von Holtzbrinck Ventures also joined the round. The capital will enable juli to scale its commercial team across the U.S., conduct clinical trials of the app, and acquire additional artificial intelligence talent.

“juli is helping patients, providers and employers identify behavioral triggers that worsen or improve the most hard-to-treat and complex chronic conditions, including asthma, migraines, depression and bipolar disorder,” said Bettina Hein, CEO and co-founder of Boston-based juli. “With the support of Speedinvest, Norrsken and our other investors, we will be able to expand our reach to improve patient health and lower health care costs.”

Hein, a serial software entrepreneur who has previously built successful technology companies and supported other entrepreneurs as an investor on Switzerland's Höhle der Löwen program, co-founded juli with Bettina Duehrkoop, a Swiss entrepreneur and Chief Marketing Officer of juli. The third co-founder is the Swiss serial entrepreneur Joris Straatman who serves as CTO. The company has its headquarters based in Boston but is also incorporated in St. Gallen, with part of its management team including co-founders in Switzerland.

(Press release)
Photo: juli

0Comments

More news about

juli AG

rss